| Subscribe To Our Free Newsletter |
Glenmark Pharma gains on reporting muti-fold jump in Q1 PAT
Glenmark Pharmaceuticals rose 1.37% to Rs 1,511.40 after the drug maker reported consolidated net profit of Rs 340.27 crore in Q1 FY25, significantly higher from Rs 14.48 crore in Q1 FY24.
